MedBiome is a biopharmaceutical company with a novel platform for the identification, screening and development of microbiome modulators. MedBiome harnesses its unique platform to advance the management of inflammatory bowel disease (IBD), Alzheimer's Disease, and colorectal cancer through patients stratification and the development of novel microbiome-targeted therapeutic and nutritional approaches.
Company Details
- Founded
- -
- Address
- Ottawa, Ontario K4a4n2, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- medbiome.ca
- Keywords
- Microbiome and Drugs.
- HQ
- Ottawa, Ontario
Medbiome Questions
Medbiome's website is medbiome.ca
Medbiome's LinkedIn profile is https://ca.linkedin.com/company/medbiome
Medbiome's industry is
Biotechnology Research
Medbiome's top competitors are
Genomadix,
Virica Biotech,
Dna Genotek,
Atg Pharma Inc.,
Mironcol,
Canurta Therapeutics,
Diagnostics Biochem Canada (Dbc),
Atorvia,
Methapharm,
Orion Biotechnology.
Medbiome's categories are Biotechnology Research
Medbiome's founding year is 2018
